BSX · 8-K · 20260729PR000051
Acquisition / Partnership / Divestiture
BOSTON SCIENTIFIC CORP · 2026-07-29 · Importance 71 · Surprise 60 · In source text
Boston Scientific invested $1.5 billion in MiRus LLC during the second quarter of 2026. The investment provided an approximately 34% equity stake in MiRus and an exclusive option to acquire its TAVR business. MiRus is developing cardiovascular and orthopedic biomaterials, implants and procedural solutions, including the SIEGEL Balloon Expandable TAVR system. The transaction is intended to expand Boston Scientific’s access to MiRus’s cardiovascular and orthopedic technology portfolio.
Key facts
- Invested $1.5 billion in MiRus LLC in return for an approximately 34% equity stake and exclusive option to acquire the MiRus TAVR business. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | realized | — | Invested $1.5 billion in MiRus LLC in return for an approximately 34% equity stake and exclusive option to acquire the MiRus TAVR business. |
| assets | positive | realized | — | Invested $1.5 billion in MiRus LLC in return for an approximately 34% equity stake and exclusive option to acquire the MiRus TAVR business. |